[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Mahato, 2004 - Google Patents

Biomaterials for delivery and targeting of proteins and nucleic acids

Mahato, 2004

Document ID
13733036810058630170
Author
Mahato R
Publication year

External Links

Snippet

Newcomers to the field of biopharmaceuticals require an understanding of the basic principles and underlying methodology involved in developing protein-and nucleic acid- based therapies for genetic and acquired diseases. Introducing the principles of polymer …
Continue reading at www.taylorfrancis.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
    • A61K47/48192—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas, polyurethanes
    • A61K47/48215—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas, polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer, dendrimer, e.g. PEG, PPG, PEO, polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Mahato Biomaterials for delivery and targeting of proteins and nucleic acids
Hu et al. Polysarcosine as an alternative to PEG for therapeutic protein conjugation
Braatz et al. Chemical approaches to synthetic drug delivery systems for systemic applications
Ekladious et al. Polymer–drug conjugate therapeutics: advances, insights and prospects
Hou et al. Protein PEPylation: a new paradigm of protein–polymer conjugation
Liu et al. Nanostructured materials designed for cell binding and transduction
He et al. pH-sensitive drug-delivery systems for tumor targeting
Jacobs et al. Polypeptide nanoparticles obtained from emulsion polymerization of amino acid N-carboxyanhydrides
Wei et al. Enzyme-and pH-sensitive branched polymer–doxorubicin conjugate-based nanoscale drug delivery system for cancer therapy
Yuan et al. A novel poly (L-glutamic acid) dendrimer based drug delivery system with both pH-sensitive and targeting functions
Yu et al. Proteins conjugated with sulfoxide-containing polymers show reduced macrophage cellular uptake and improved pharmacokinetics
Tully et al. Polyglycerol for half-life extension of proteins—alternative to PEGylation?
Ryan et al. Advances in PEGylation of important biotech molecules: delivery aspects
JP5312050B2 (en) Split-type degradable polymers and composites produced therefrom
Zhang et al. pH-sensitive assembly of light-harvesting dendrimer zinc porphyrin bearing peripheral groups of primary amine with poly (ethylene glycol)-b-poly (aspartic acid) in aqueous solution
Chen et al. Discrete libraries of amphiphilic poly (ethylene glycol) graft copolymers: synthesis, assembly, and bioactivity
US8252846B2 (en) Strategies for delivery of active agents using micelles and particles
US8716422B2 (en) Anionic charge-dynamic polymers for release of cationic agents
Soliman et al. Multicomponent synthetic polymers with viral-mimetic chemistry for nucleic acid delivery
Wilms et al. Catechol-initiated polyethers: multifunctional hydrophilic ligands for PEGylation and functionalization of metal oxide nanoparticles
Heffernan et al. Disulfide-crosslinked polyion micelles for delivery of protein therapeutics
Zhou et al. Biodegradable polysarcosine with inserted alanine residues: synthesis and enzymolysis
Song et al. Preparation, characterization, and in vitro evaluation of amphiphilic peptide P12 and P12-DOX nanomicelles as antitumor drug carriers
Stepanova et al. Polypeptide-based systems: From synthesis to application in drug delivery
Honda et al. Sequentially self-assembled nanoreactor comprising tannic acid and phenylboronic acid-conjugated polymers inducing tumor-selective enzymatic activity